Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
1,938
-20.07%
|
$65,892
$34.0 P/Share
|
|
Feb 26
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,494
-1.66%
|
$84,796
$34.8 P/Share
|
|
Feb 26
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,617
+3.59%
|
-
|
|
Feb 26
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-1.47%
|
$103,666
$34.8 P/Share
|
|
Feb 26
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,866
+3.21%
|
-
|
|
Feb 26
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-3.77%
|
$103,666
$34.8 P/Share
|
|
Feb 26
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,866
+7.83%
|
-
|
|
Feb 26
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,695
-1.8%
|
$125,630
$34.8 P/Share
|
|
Feb 26
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,322
+3.9%
|
-
|
|
Feb 26
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,402
-2.52%
|
$81,668
$34.8 P/Share
|
|
Feb 26
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,409
+5.37%
|
-
|
|
Feb 26
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
808
-7.72%
|
$27,472
$34.8 P/Share
|
|
Feb 26
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,746
+20.79%
|
-
|
|
Feb 25
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
3,743
-32.66%
|
$131,005
$35.26 P/Share
|
|
Feb 23
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-4.41%
|
$119,490
$35.32 P/Share
|
|
Feb 23
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,689
+9.04%
|
-
|
|
Feb 23
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,846
-3.07%
|
$99,610
$35.32 P/Share
|
|
Feb 23
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,408
+6.46%
|
-
|
|
Feb 23
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,587
-1.75%
|
$90,545
$35.32 P/Share
|
|
Feb 23
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,825
+3.8%
|
-
|
|
Feb 23
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
672
-5.54%
|
$23,520
$35.32 P/Share
|
|
Feb 23
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,284
+15.84%
|
-
|
|
Feb 23
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,880
-1.93%
|
$135,800
$35.32 P/Share
|
|
Feb 23
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,738
+4.17%
|
-
|
|
Feb 23
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-1.67%
|
$119,490
$35.32 P/Share
|
|
Feb 23
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,689
+3.63%
|
-
|
|
Feb 22
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,452
-7.26%
|
$190,820
$35.32 P/Share
|
|
Feb 22
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,279
+14.05%
|
-
|
|
Feb 22
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,157
-3.53%
|
$110,495
$35.32 P/Share
|
|
Feb 22
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,109
+7.36%
|
-
|
|
Feb 22
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,154
-2.18%
|
$110,390
$35.32 P/Share
|
|
Feb 22
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,109
+4.67%
|
-
|
|
Feb 22
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
983
-9.08%
|
$34,405
$35.32 P/Share
|
|
Feb 22
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
3,114
+22.33%
|
-
|
|
Feb 22
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,305
-2.19%
|
$150,675
$35.32 P/Share
|
|
Feb 22
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,694
+4.71%
|
-
|
|
Feb 22
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,300
-1.65%
|
$115,500
$35.32 P/Share
|
|
Feb 22
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,432
+3.59%
|
-
|
|
Feb 20
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
1,327
-14.67%
|
$46,445
$35.69 P/Share
|
|
Feb 18
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-2.07%
|
$138,250
$35.9 P/Share
|
|
Feb 18
2025
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,896
+4.46%
|
-
|
|
Feb 18
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,869
-1.34%
|
$65,415
$35.9 P/Share
|
|
Feb 18
2025
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+4.35%
|
-
|
|
Feb 18
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,822
-1.45%
|
$98,770
$35.9 P/Share
|
|
Feb 18
2025
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+3.16%
|
-
|
|
Feb 18
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,869
-2.22%
|
$65,415
$35.9 P/Share
|
|
Feb 18
2025
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,354
+7.02%
|
-
|
|
Feb 18
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
706
-7.24%
|
$24,710
$35.9 P/Share
|
|
Feb 18
2025
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,033
+17.25%
|
-
|
|
Feb 18
2025
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,950
-5.92%
|
$138,250
$35.9 P/Share
|